Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FL5SD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,332
Award facts
- Contract value 100% obligated
- $8,331.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a type of contraceptive implant, with a ceiling value of $8,331.72 and a period of performance ending on February 6, 2025.
DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. This contract is not associated with a specific set-aside designation, allowing the company to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.
In addition to this Delivery Order, DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of Department of Defense healthcare sites worldwide.
Quick answers
Who was awarded contract SPE2DB25FL5SD?
SPE2DB25FL5SD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 15, 2025.
How much is contract SPE2DB25FL5SD worth?
The government has obligated $8,332 on SPE2DB25FL5SD.
Is contract SPE2DB25FL5SD an order under another contract?
Yes. SPE2DB25FL5SD is a delivery order under SPE2DB22D9209, an indefinite delivery contract.
Was contract SPE2DB25FL5SD competed?
The extent of competition for SPE2DB25FL5SD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award